The North America ophthalmology drugs and devices market holds a high growth potential for the near future due to factors like rising geriatric population, increase in strategic initiatives by large market players present in the region and increasing prevalence of ocular diseases. Over the forecast period of 2018-2026, the North America ophthalmology drugs and device market is expected to witness a CAGR of 5.91%.
NORTH AMERICA Â OPTHALMOLOGY DRUGS AND DEVICES MARKET FORECAST 2018-2026
North America Ophthalmology Drugs & Devices Market Is Segmented by Ophthalmic Devices(Diagnostic & Monitoring Equipment, Surgery Device) by Vision Care(Contact Lens, Spectacles, Eye Exams) by Ophthalmic Drugs( by Prescription Type, by Drug Delivery Types, by Type of Disease, by Therapeutics) by End User(Hospitals, Eye Clinics, Diagnostic Centers, Patients) & Geography.
The North America ophthalmology drugs and devices market holds a high growth potential for the near future due to factors like rising geriatric population, increase in strategic initiatives by large market players present in the region and increasing prevalence of ocular diseases. Over the forecast period of 2018-2026, the North America ophthalmology drugs and device market is expected to witness a CAGR of 5.91%.
The United States and Canada are the key markets in this region. The US ophthalmology drugs and devices market has significant growth opportunities. The country has the world’s leading healthcare infrastructure and technologies, thus enabling it to manufacture ophthalmology drugs economically. The Canada ophthalmology drugs and device market is progressing on the same line. The growth in the Canada region is majorly influenced by increasing innovations in the ophthalmology market, rising prevalence of eye diseases, and increasing elderly population.
Eminent companies in the ophthalmology drugs and device market include Pfizer, GlaxoSmithKline, Santen Pharmaceutical Co Ltd, Johnson & Johnson Inc, Allergan Inc, Valent Pharmaceuticals International Inc, Bayer, Ziemer Group Holding Ag, Roche Holding Ag, and Novartis International Ag.
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE
- STUDY GOALS
- SCOPE OF THE MARKET STUDY
- WHO WILL FIND THIS REPORT USEFUL?
- STUDY AND FORECASTING YEARS
- RESEARCH METHODOLOGY
- SOURCES OF DATA
- SECONDARY DATA
- PRIMARY DATA
- TOP DOWN APPROACH
- BOTTOM-UP APPROACH
- DATA TRIANGULATION
- SOURCES OF DATA
- EXECUTIVE SUMMARY
- MARKET SUMMARY
- KEY FINDINGS
- VISION CARE DEVICES ARE DOMINATING THE MARKET
- GLAUCOMA DRUGS ARE MAJORLY USED
- RISING PREVALENCE OF EYE RELATED DISEASES
- MARKET DETERMINANTS
- MARKET DRIVERS
- INCREASING PREVALENCE OF DIABETES INCREASES THE PROBABILITY OF OPHTHALMIC DISORDERS
- TECHNOLOGICAL ADVANCEMENT
- INCREASE IN HEALTHCARE EXPENDITURE
- MARKET RESTRAINTS
- RENOWNED DRUGS GOING OFF-PATENT
- DELAY IN DRUG APPROVALS
- AWARENESS RELATED TO OPHTHALMOLOGY DRUGS ARE LOW
- MARKET OPPORTUNITIES
- INCREASE IN DISORDER SYMPTOM AND IMPROVED DIAGNOSIS LEADING TO HIGHER TREATMENT RATES
- INCREASING DEMAND FOR INTRAOCULAR LENSES AND PHACOEMULSIFICATION DEVICES
- MARKET CHALLENGES
- VARIOUS RISK AND COMPLICATIONS ASSOCIATED WITH THE TREATMENT OF OCULAR DISEASES
- MARKET DRIVERS
- MARKET SEGMENTATION
- MARKET BY DRUGS AND DEVICES 2018-2026
- DEVICES
- DIAGNOSTIC & MONITORING EQUIPMENT
- OPTICAL COHERENCE TOMOGRAPHY
- OPHTHALMIC ULTRASOUND IMAGING SYSTEMS
- FUNDUS CAMERA MARKET
- OPHTHALMOSCOPES
- RETINOSCOPE
- PACHYMETER
- WAVEFRONT ABERROMETERS
- PERIMETERS/VISUAL FIELD ANALYZER
- AUTOREFRACTORS/PHOROPTER
- SPECULAR MICROSCOPE
- CORNEAL TOPOGRAPHERS
- OTHER DIAGNOSTIC & MONITORING EQUIPMENT MARKET
- SURGERY DEVICE
- CATARACT SURGERY DEVICES
- GLAUCOMA SURGERY DEVICES
- REFRACTIVE SURGERY DEVICES
- VITREORETINAL SURGERY DEVICES
- VISION CARE
- DIAGNOSTIC & MONITORING EQUIPMENT
- DRUGS
- GLAUCOMA DRUG
- RETINAL DISORDER DRUG
- DRY EYE DRUG
- ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG
- DEVICES
- MARKET BY DRUGS AND DEVICES 2018-2026
- KEY ANALYTICS
- PORTER’S FIVE FORCES ANALYSIS
- BARGAINING POWER OF BUYERS
- BARGAINING POWER OF SUPPLIER
- THREATS OF NEW ENTRANTS
- THREATS OF SUBSTITUTES
- COMPETITIVE RIVALRY
- VALUE CHAIN ANALYSIS
- RESEARCH AND DEVELOPMENT
- MANUFACTURING
- DISTRIBUTORS
- END USERS
- KEY BUYING CRITERIA
- COST
- EFFICACY
- ACCESSIBILITY
- INNOVATION
- SUPPLY CHAIN ANALYSIS
- SUPPLIERS
- MANUFACTURERS
- DISTRIBUTORS AND RETAILERS
- END USERS
- REGULATORY FRAMEWORK
- PORTER’S FIVE FORCES ANALYSIS
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- THE UNITED STATES
- CANADA
- NORTH AMERICA
- COMPANY PROFILES
- COMPETITIVE ANALYSIS
- MARKET SHARE ANALYSIS
- TOP COMPANIES
- ESSILOR INTERNATIONAL S.A. (FRANCE)
- JOHNSON & JOHNSON INC. (U.S.)
- ALLERGAN PLC (U.S.)
- NOVARTIS INTERNATIONAL AG (SWITZERLAND)
- VALENT PHARMACEUTICALS INTERNATIONAL INC. (U.S.)
- ALLERGAN INC.
- COMPANY OVERVIEW
- PRODUCT & SERVICES
- SWOT ANALYSIS
- STRATEGIC INITIATIVES
- BAYER
- COMPANY OVERVIEW
- PRODUCT & SERVICES
- SWOT ANALYSIS
- STRATEGIC INITIATIVES
- CARL ZEISS AG
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SWOT ANALYSIS
- STRATEGIC INITIATIVE
- ESSILOR INTERNATIONAL S.A.
- COMPANY OVERVIEW
- PRODUCT & SERVICES
- SWOT ANALYSIS
- STRATEGIC INITIATIVE
- GLAXOSMITHKLINE
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SWOT ANALYSIS
- JOHNSON & JOHNSON INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- NOVARTIS INTERNATIONAL AG
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- PFIZER
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- ROCHE HOLDING AG
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- SANTEN PHARMACEUTICAL CO., LTD.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- SUN PHARMACEUTICALS INDUSTRIES, LTD
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- VALENT PHARMACEUTICALS INTERNATIONAL INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- ZIEMER GROUP HOLDING AG
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- COMPETITIVE ANALYSIS
LIST OF TABLES
TABLE 1Â Â Â Â Â Â NORTH AMERICA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026
TABLE 2Â Â Â Â Â Â PREVALENCE OF EYE DISEASES IN US 2014 & 2030
TABLE 3Â Â Â Â Â Â COMMON CAUSES OF LOSS OF VISION IN THE ELDERLY
TABLE 4Â Â Â Â Â Â SELECTED LIST OF GLAUCOMA DRUGS IN LATE-STAGE CLINICAL TRIALS
TABLE 5Â Â Â Â Â Â EYE DRUGS GONE OFF-PATENT
TABLE 6Â Â Â Â Â Â NORTH AMERICA OPTHALMOLOGY DRUGS AND DEVICES MARKET BY DRUGS AND DEVICES 2018-2026 ($ MILLION)
TABLE 7Â Â Â Â Â Â NORTH AMERICA DRUGS AND DEVICES MARKET IN DEVICES 2018-2026 ($ MILLION)
TABLE 8Â Â Â Â Â Â NORTH AMERICA DEVICES MARKET IN DIAGNOSTIC & MONITORING EQUIPMENTÂ BY TYPES 2018-2026 ($ MILLION)
TABLE 9Â Â Â Â Â Â NORTH AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPTICAL COHERENCE TOMOGRAPHY 2018-2026 ($ MILLION)
TABLE 10Â Â Â Â NORTH AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPHTHALMIC ULTRASOUND IMAGING SYSTEMS 2018-2026 ($ MILLION)
TABLE 11Â Â Â Â NORTH AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN FUNDUS CAMERA MARKET 2018-2026 ($ MILLION)
TABLE 12Â Â Â Â NORTH AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPHTHALMOSCOPES 2018-2026 ($ MILLION)
TABLE 13Â Â Â Â NORTH AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN RETINOSCOPE 2018-2026 ($ MILLION)
TABLE 14Â Â Â Â NORTH AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN PACHYMETER 2018-2026 ($ MILLION)
TABLE 15Â Â Â Â NORTH AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN WAVEFRONT ABERROMETERS 2018-2026 ($ MILLION)
TABLE 16Â Â Â Â NORTH AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN PERIMETERS/VISUAL FIELD ANALYZER 2018-2026 ($ MILLION)
TABLE 17Â Â Â Â NORTH AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN AUTOREFRACTORS/PHOROPTER 2018-2026 ($ MILLION)
TABLE 18Â Â Â Â NORTH AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN SPECULAR MICROSCOPE 2018-2026 ($ MILLION)
TABLE 19Â Â Â Â NORTH AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN CORNEAL TOPOGRAPHERS 2018-2026 ($ MILLION)
TABLE 20Â Â Â Â NORTH AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OTHER DIAGNOSTIC & MONITORING EQUIPMENT MARKET 2018-2026 ($ MILLION)
TABLE 21Â Â Â Â NORTH AMERICA DEVICES MARKET IN SURGERY DEVICE BY TYPES 2018-2026 ($ MILLION)
TABLE 22Â Â Â Â NORTH AMERICA SURGERY DEVICES MARKET IN CATARACT SURGERY DEVICES 2018-2026 ($ MILLION)
TABLE 23Â Â Â Â NORTH AMERICA SURGERY DEVICES MARKET IN GLAUCOMA SURGERY DEVICES 2018-2026 ($ MILLION)
TABLE 24Â Â Â Â NORTH AMERICA SURGERY DEVICES MARKET IN REFRACTIVE SURGERY DEVICES 2018-2026 ($ MILLION)
TABLE 25Â Â Â Â NORTH AMERICA SURGERY DEVICES MARKET IN VITREORETINAL SURGERY DEVICES 2018-2026 ($ MILLION)
TABLE 26Â Â Â Â NORTH AMERICA DEVICES MARKET IN VISION CARE MARKET 2018-2026 ($ MILLION)
TABLE 27Â Â Â Â NORTH AMERICA DRUGS AND DEVICES MARKET IN DRUGS BY TYPES 2018-2026 ($ MILLION)
TABLE 28Â Â Â Â NORTH AMERICA DRUGS MARKET IN GLAUCOMA DRUG 2018-2026 ($ MILLION)
TABLE 29Â Â Â Â NORTH AMERICA DRUGS MARKET IN RETINAL DISORDER DRUG 2018-2026 ($ MILLION)
TABLE 30Â Â Â Â NORTH AMERICA DRUGS MARKET IN DRY EYE DRUG 2018-2026 ($ MILLION)
TABLE 31Â Â Â Â NORTH AMERICA DRUGS MARKET IN ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG 2018-2026 ($ MILLION)
TABLE 32Â Â Â Â NORTH AMERICA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)
LIST OF FIGURES
FIGURE 1Â Â Â Â NORTH AMERICA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026
FIGURE 2Â Â Â Â NORTH AMERICA DRUGS AND DEVICES MARKET IN DEVICES 2018-2026 ($ MILLION)
FIGURE 3Â Â Â Â NORTH AMERICA DEVICES MARKET DIAGNOSTIC & MONITORING EQUIPMENT IN 2018-2026 ($ MILLION)
FIGURE 4Â Â Â Â NORTH AMERICA DEVICES MARKET IN SURGERY DEVICE 2018-2026 ($ MILLION)
FIGURE 5Â Â Â Â NORTH AMERICA DEVICES MARKET IN VISION CARE MARKET 2018-2026 ($ MILLION)
FIGURE 6Â Â Â Â NORTH AMERICA DRUGS AND DEVICES MARKET IN DRUGS 2018-2026 ($ MILLION)
FIGURE 7Â Â Â Â NORTH AMERICA DRUGS MARKET IN GLAUCOMA DRUG 2018-2026 ($ MILLION)
FIGURE 8Â Â Â Â NORTH AMERICA DRUGS MARKET IN RETINAL DISORDER DRUG 2018-2026 ($ MILLION)
FIGURE 9Â Â Â Â NORTH AMERICA DRUGS MARKET IN DRY EYE DRUG 2018-2026 ($ MILLION)
FIGURE 10Â Â NORTH AMERICA DRUGS MARKET IN ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG 2018-2026 ($ MILLION)
FIGURE 11Â Â NORTH AMERICA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)
FIGURE 12Â Â THE UNITED STATES OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)
FIGURE 13Â Â CANADA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)
FIGURE 14Â Â OPHTHALMOLOGY DEVICES COMPANY MARKET SHARE 2017 (%)
FIGURE 15Â Â OPHTHALMOLOGY DRUGS COMPANY MARKET SHARE 2017 (%)
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- THE UNITED STATES
- CANADA
- NORTH AMERICA
- MARKET SEGMENTATION
- MARKET BY DRUGS AND DEVICES 2018-2026
- DEVICES
- DIAGNOSTIC & MONITORING EQUIPMENT
- OPTICAL COHERENCE TOMOGRAPHY
- OPHTHALMIC ULTRASOUND IMAGING SYSTEMS
- FUNDUS CAMERA MARKET
- OPHTHALMOSCOPES
- RETINOSCOPE
- PACHYMETER
- WAVEFRONT ABERROMETERS
- PERIMETERS/VISUAL FIELD ANALYZER
- AUTOREFRACTORS/PHOROPTER
- SPECULAR MICROSCOPE
- CORNEAL TOPOGRAPHERS
- OTHER DIAGNOSTIC & MONITORING EQUIPMENT MARKET
- SURGERY DEVICE
- CATARACT SURGERY DEVICES
- GLAUCOMA SURGERY DEVICES
- REFRACTIVE SURGERY DEVICES
- VITREORETINAL SURGERY DEVICES
- VISION CARE
- DIAGNOSTIC & MONITORING EQUIPMENT
- DRUGS
- GLAUCOMA DRUG
- RETINAL DISORDER DRUG
- DRY EYE DRUG
- ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG
- DEVICES
- MARKET BY DRUGS AND DEVICES 2018-2026
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.